---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-143750"
form_type: "8-K"
ticker: "AVIR"
cik: "0001593899"
company_name: "Atea Pharmaceuticals, Inc."
filed_at: "2025-06-20T23:59:59+00:00"
generated_at: "2026-05-19T01:23:49.613476+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Atea shareholders elect three Class II directors, ratify KPMG, approve executive compensation

## Summary
- Bruno Lucidi, Polly Murphy, and Bruce Polsky elected as Class II directors to 2028 term.
- Ratification of KPMG as independent auditor for FY2025 approved with 73.8M votes for.
- Advisory (non-binding) approval of named executive officer compensation received 46.5M votes for.
- Approximately 87.6% of outstanding shares represented at June 20, 2025 annual meeting.

## SEC filing metadata
- accession: 0001193125-25-143750
- form_type: 8-K
- ticker: AVIR
- cik: 0001593899
- company_name: Atea Pharmaceuticals, Inc.
- filed_at: 2025-06-20T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1593899/000119312525143750/0001193125-25-143750-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1593899/000119312525143750/d936449d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-143750
- JSON: https://secwatch.observer/filing/0001193125-25-143750.json
- Plain text: https://secwatch.observer/filing/0001193125-25-143750.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.